Company Filing History:
Years Active: 2022-2023
Title: Yen-Ying Chen: Innovator in Therapeutic Antibodies
Introduction
Yen-Ying Chen is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of therapeutic antibodies, focusing on innovative solutions for cancer treatment. With a total of 2 patents, his work is paving the way for advancements in medical therapies.
Latest Patents
Yen-Ying Chen's latest patents involve humanized antibodies and antigen-binding fragments that specifically target biantennary Lewis antigens. These antigens are expressed in various cancers, making the disclosed antibodies crucial for targeting antigen-expressing cells. The patents also cover polynucleotides, vectors, and host cells for producing these antibodies and their fragments. Furthermore, the patents include pharmaceutical compositions, methods of treatment, and detection, showcasing the versatility and applicability of his inventions in combating cancer.
Career Highlights
Yen-Ying Chen is associated with Glyconex, Inc., where he continues to develop groundbreaking therapeutic solutions. His expertise in antibody technology has positioned him as a key player in the biotechnology sector.
Collaborations
Yen-Ying Chen collaborates with talented individuals such as Tong-Hsuan Chang and Mei-Chun Yang, who contribute to the innovative environment at Glyconex, Inc. Their combined efforts enhance the research and development of therapeutic antibodies.
Conclusion
Yen-Ying Chen's work in therapeutic antibodies represents a significant advancement in cancer treatment. His innovative patents and collaborations highlight his commitment to improving healthcare through scientific research.